- Parsortix HER2 assay showcased at AACR 2024
- Parsortix at European breast cancer conference
- Potential utility in precision oncology
- Standard form for notification of major holdings
- Breakthrough clinical results
- Contract announcement with Eisai Inc.
- Broker Announcement
- Parsortix unlocks opportunities for drug discovery
- ANGLE launches Portrait+ CTC kit at SABCS
- Launch of PD-L1 test to support cancer studies
More ▼
Key statistics
On Friday, Angle PLC (AGL:LSE) closed at 12.00, 32.35% above the 52 week low of 9.07 set on Nov 13, 2023.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 11.75 |
---|---|
High | 16.00 |
Low | 16.00 |
Bid | 11.50 |
Offer | 13.50 |
Previous close | 11.75 |
Average volume | 1.43m |
---|---|
Shares outstanding | 260.58m |
Free float | 232.60m |
P/E (TTM) | -- |
Market cap | 30.62m GBP |
EPS (TTM) | -0.086 GBP |
Data delayed at least 20 minutes, as of Apr 19 2024 17:08 BST.
More ▼